Yoshihiro Izumiya
Overview
Explore the profile of Yoshihiro Izumiya including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
65
Citations
1838
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Inagaki T, Espera J, Wang K, Komaki S, Nair S, Davis R, et al.
bioRxiv
. 2025 Mar;
PMID: 40027700
Kaposi's sarcoma-associated herpesvirus (KSHV) is the causative agent of Kaposi's sarcoma (KS) and two human lymphoproliferative diseases: primary effusion lymphoma and AIDS-related multicentric Castleman's disease. KSHV-encoded latency-associated nuclear antigen (LANA)...
2.
Komaki S, Inagaki T, Kumar A, Izumiya Y
Viruses
. 2025 Jan;
16(12.
PMID: 39772207
Kaposi's sarcoma-associated herpesvirus (KSHV) is a double-stranded DNA gamma herpesvirus. Like other herpesviruses, KSHV establishes a latent infection with limited gene expression, while KSHV occasionally undergoes the lytic replication phase,...
3.
4.
Miura H, Wang K, Inagaki T, Chuang F, Shimoda M, Izumiya C, et al.
Cell Chem Biol
. 2024 Nov;
31(11):1909-1925.e7.
PMID: 39488208
Kaposi's sarcoma-associated herpesvirus (KSHV) establishes a latent infection, and viral genes are poised to be transcribed in the latent chromatin. In the poised chromatins, KSHV latency-associated nuclear antigen (LANA) interacts...
5.
Inagaki T, Kumar A, Komaki S, Nakajima K, Izumiya Y
Virology
. 2024 Jun;
597:110146.
PMID: 38909515
Kaposi's sarcoma-associated herpesvirus (KSHV) is an oncogenic γ-herpesvirus with a double-stranded DNA capable of establishing latent infection in the host cell. During latency, only a limited number of viral genes...
6.
Izumiya Y, Algalil A, Espera J, Miura H, Izumiya C, Inagaki T, et al.
J Virol
. 2024 Jan;
98(2):e0138623.
PMID: 38240593
The Kaposi's sarcoma-associated herpesvirus (KSHV) genome consists of an approximately 140-kb unique coding region flanked by 30-40 copies of a 0.8-kb terminal repeat (TR) sequence. A gene enhancer recruits transcription-related...
7.
Nakajima K, Inagaki T, Espera J, Izumiya Y
J Virol
. 2024 Jan;
98(2):e0126823.
PMID: 38240588
Protein knockdown with an inducible degradation system is a powerful tool for studying proteins of interest in living cells. Here, we adopted the auxin-inducible degron (AID) approach to detail Kaposi's...
8.
Inagaki T, Wang K, Kumar A, Izumiya C, Miura H, Komaki S, et al.
PLoS Pathog
. 2023 Nov;
19(11):e1011771.
PMID: 37934757
Kaposi sarcoma-associated herpesvirus (KSHV) inflammatory cytokine syndrome (KICS) is a newly described chronic inflammatory disease condition caused by KSHV infection and is characterized by high KSHV viral load and sustained...
9.
Shimoda M, Inagaki T, Davis R, Merleev A, Tepper C, Maverakis E, et al.
PLoS Pathog
. 2023 Oct;
19(10):e1011703.
PMID: 37883374
Kaposi's sarcoma-associated herpesvirus (KSHV) is an oncogenic double-stranded DNA virus and the etiologic agent of Kaposi's sarcoma and hyperinflammatory lymphoproliferative disorders. Understanding the mechanism by which KSHV increases the infected...
10.
Inagaki T, Wang K, Kumar A, Izumiya C, Miura H, Komaki S, et al.
bioRxiv
. 2023 Jul;
PMID: 37503036
Kaposi sarcoma-associated herpesvirus (KSHV) inflammatory cytokine syndrome (KICS) is a newly described chronic inflammatory disease condition caused by KSHV infection and is characterized by high KSHV viral load and sustained...